Camber Capital Management as of Sept. 30, 2015
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 43 positions in its portfolio as reported in the September 2015 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| AstraZeneca (AZN) | 11.3 | $138M | 4.3M | 31.82 | |
| Teva Pharmaceutical Industries (TEVA) | 9.2 | $113M | 2.0M | 56.46 | |
| Medicines Company | 7.7 | $95M | 2.5M | 37.96 | |
| Cyberonics | 5.0 | $61M | 1.0M | 60.78 | |
| Mylan Nv | 4.9 | $60M | 1.5M | 40.26 | |
| NuVasive | 4.3 | $53M | 1.1M | 48.22 | |
| Genomic Health | 4.2 | $52M | 2.5M | 21.16 | |
| Orthofix International Nv Com Stk | 4.1 | $51M | 1.5M | 33.75 | |
| Express Scripts Holding | 4.0 | $49M | 600k | 80.96 | |
| Select Medical Holdings Corporation (SEM) | 3.8 | $47M | 4.4M | 10.79 | |
| Laboratory Corp. of America Holdings | 3.5 | $43M | 400k | 108.47 | |
| Mead Johnson Nutrition | 3.5 | $42M | 600k | 70.40 | |
| Universal American | 3.3 | $40M | 5.9M | 6.84 | |
| Masimo Corporation (MASI) | 3.1 | $39M | 1.0M | 38.56 | |
| Ariad Pharmaceuticals | 2.6 | $32M | 5.5M | 5.84 | |
| Nektar Therapeutics (NKTR) | 2.0 | $25M | 2.3M | 10.96 | |
| Sequenom | 1.7 | $21M | 12M | 1.75 | |
| Cross Country Healthcare (CCRN) | 1.7 | $20M | 1.5M | 13.61 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $20M | 250k | 80.36 | |
| HMS Holdings | 1.6 | $19M | 2.2M | 8.77 | |
| Arena Pharmaceuticals | 1.5 | $19M | 9.8M | 1.91 | |
| Tenet Healthcare Corporation | 1.5 | $19M | 500k | 36.92 | |
| Kindred Healthcare | 1.4 | $17M | 1.1M | 15.75 | |
| Innocoll | 1.1 | $14M | 1.1M | 12.68 | |
| Quest Diagnostics Incorporated (DGX) | 1.1 | $13M | 219k | 61.47 | |
| Amarin Corporation (AMRN) | 1.0 | $13M | 6.5M | 1.93 | |
| Abbott Laboratories (ABT) | 1.0 | $12M | 300k | 40.22 | |
| DURECT Corporation | 0.9 | $12M | 6.0M | 1.95 | |
| BioScrip | 0.9 | $11M | 6.0M | 1.87 | |
| OraSure Technologies (OSUR) | 0.7 | $8.9M | 2.0M | 4.44 | |
| Protalix BioTherapeutics | 0.7 | $8.6M | 7.3M | 1.18 | |
| Epirus Biopharmaceuticals In | 0.7 | $8.2M | 1.8M | 4.42 | |
| Catabasis Pharmaceuticals | 0.7 | $8.1M | 1.0M | 8.09 | |
| Invitae (NVTAQ) | 0.5 | $6.5M | 894k | 7.22 | |
| Insulet Corporation (PODD) | 0.5 | $6.3M | 245k | 25.91 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.5 | $6.2M | 9.0M | 0.69 | |
| GenMark Diagnostics | 0.5 | $5.7M | 724k | 7.87 | |
| Biolase Technology | 0.4 | $4.8M | 5.3M | 0.90 | |
| Veracyte (VCYT) | 0.3 | $4.3M | 910k | 4.69 | |
| AngioDynamics (ANGO) | 0.3 | $3.4M | 258k | 13.19 | |
| Unilife US | 0.2 | $2.7M | 2.8M | 0.98 | |
| Cardica | 0.2 | $2.4M | 8.4M | 0.29 | |
| Catalyst Biosciences | 0.1 | $899k | 193k | 4.66 |
